To be frank, I only notice (and bought heavily into) DXB after the turn of events on Friday. Scrutinising the data, I am satisfied that the signals are there for this drug to be a blockbuster still.
There is no magic bullet to treat CKD as the disease is progressive, doesn't matter whether one is on ARB/ACE inhibitor or not, it will progress!!! The aim is to SLOW the progression and the trials thus far has not shown that it cannot do this, and hence my big punt.
Anyone interested in biotech, check out MSB and CYP which I also hold. Stem cell is the next frontier!
Obviously DYOR, I have done mine
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-340
-
- There are more pages in this discussion • 288 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $214.4M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.0¢ | $503.5K | 1.322M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 26318 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 170072 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |